Paloma Partners Management CO Alnylam Pharmaceuticals, Inc. Call Options Transaction History

Paloma Partners Management CO

  • $3.08 Billion
  • Q3 2024

Call Options

5 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q2 2024

Aug 14, 2024
BUY
$143.31 - $247.0 $114,648 - $197,600
800 New
800 $194,000
Q3 2023

Nov 14, 2023
BUY
$170.77 - $211.65 $290,309 - $359,805
1,700 New
1,700 $301,000
Q4 2020

Feb 16, 2021
SELL
$122.97 - $147.0 $639,444 - $764,400
-5,200 Closed
0 $0
Q3 2020

Nov 16, 2020
SELL
$121.19 - $165.49 $799,854 - $1.09 Million
-6,600 Reduced 55.93%
5,200 $757,000
Q2 2018

Aug 14, 2018
BUY
$88.31 - $107.8 $1.04 Million - $1.27 Million
11,800 New
11,800 $1.16 Million

Others Institutions Holding ALNY

# of Institutions
644
Shares Held
109M
Call Options Held
1.28M
Put Options Held
1.21M
View Full List

About ALNYLAM PHARMACEUTICALS, INC.

ALNY Quotes by TradingView
  • Ticker ALNY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 123,028,000
  • Market Cap $30.2B
  • Description
  • Alnylam Pharmaceuticals, Inc., a biopharmaceutical company, focuses on discovering, developing, and commercializing novel therapeutics based on ribonucleic acid interference. The company's pipeline of investigational RNAi therapeutics focuses on genetic medicines, cardio-metabolic diseases, hepatic infectious diseases, and central nervous system...
More about ALNY
Track This Portfolio

Track Paloma Partners Management CO Portfolio

Follow Paloma Partners Management CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Paloma Partners Management CO, based on Form 13F filings with the SEC.

News

Stay updated on Paloma Partners Management CO with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email